Association of INSIG2 rs9308762 With ALT Level Independent of BMI

Guan, Li*; Shang, Xiao-Rui*; Liu, Fang-Hong*; Song, Jie-Yun; Ma, Jun*; Wang, Hai-Jun*

Journal of Pediatric Gastroenterology & Nutrition:
doi: 10.1097/MPG.0b013e3182a87b71
Original Articles: Hepatology and Nutrition

Objectives: An increasing number of people are at risk for developing nonalcoholic fatty liver disease (NAFLD). Because obesity is a risk factor for NAFLD, the common variants of obesity-susceptible genes may be associated with NAFLD. Our aim was to identify whether the obesity-susceptible gene variants (rs9939609, rs9930506, and rs4783819 in fat mass and obesity-associated gene (FTO); rs12970134 and rs17782313 in melanocortin-4 receptor gene (MC4R); and rs7566605, rs13428113, and rs9308762 in insulin-induced gene 2 [INSIG2]) were associated with NAFLD.

Methods: The case-control study recruited 1027 Chinese children ages 7 to 18 years, including 162 children with NAFLD and 865 children without NAFLD. Anthropometric measurements, alanine transaminase (ALT) detection, liver ultrasound examination, and genotyping of 8 gene variants were performed.

Results: The A-allele of FTO rs9939609 was associated with increased NAFLD risk (P = 0.029, odds ratio 1.43), but was not significant after being adjusted for body mass index (BMI) (P = 0.268). We also found an association between the 2 variants (rs12970134 in MC4R and rs9308762 in INSIG2) and ALT level. For rs12970134, each additional A-allele increased ALT level by 1.87 IU/L (P = 0.032). For rs9308762, the homozygotes of the C-allele had a higher ALT level than the T-allele carriers (β = 3.19, P = 0.007). After adjustment for BMI, the former association did not exist, whereas the latter reminded significant (P = 0.003).

Conclusions: The FTO rs9939609 A-allele increased risk of NAFLD and MC4R rs12970134 was associated with ALT level through an effect on BMI. The association between INSIG2 rs9308762 and ALT level was independent of BMI. The results provided evidence for identifying genetic factors of NAFLD and may be useful for risk assessment and personalized medicine of NAFLD.

Author Information

*Institute of Child and Adolescent Health

Division of Maternal and Child Health, School of Public Health, Peking University, Beijing, China.

Address correspondence and reprint requests to Dr Hai-Jun Wang, Associate Professor, Institute of Child and Adolescent Health, School of Public Health, Peking University, No. 38 Xueyuan Road Beijing, Haidian District, Beijing 100-191, China (e-mail:

Received 7 August, 2013

Accepted 7 August, 2013

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (

The study was supported by a grant from the National Natural Science Foundation of China (81172683), and the Major State Basic Research and Development Program of China (973 program) (2012CB517500).

The authors report no conflicts of interests.

© 2014 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology,